Ultra-Low-Dose Rituximab for the Treatment of Refractory Pemphigus Vulgaris with a History of Treated Pulmonary Tuberculosis: A Case Report
Clinical, Cosmetic and Investigational Dermatology · 2026-11 · Volume 19 · 1-5
DOI: 10.2147/ccid.s647223 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-11. Verfasst von Fangyan Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Me…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, People's Republic of China.
ORCID-Profile: Fangyan Zhou
Zitieren
APA
Zhou, F., & Zhu, C. (2026). Ultra-Low-Dose Rituximab for the Treatment of Refractory Pemphigus Vulgaris with a History of Treated Pulmonary Tuberculosis: A Case Report. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-5. https://doi.org/10.2147/ccid.s647223
Vancouver
Zhou F, Zhu C. Ultra-Low-Dose Rituximab for the Treatment of Refractory Pemphigus Vulgaris with a History of Treated Pulmonary Tuberculosis: A Case Report. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-5. doi:10.2147/ccid.s647223
BibTeX
@article{Zhou2026,
author = {Zhou, Fangyan and Zhu, Chengyao},
title = {Ultra-Low-Dose Rituximab for the Treatment of Refractory Pemphigus Vulgaris with a History of Treated Pulmonary Tuberculosis: A Case Report},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2026},
volume = {Volume 19},
pages = {1--5},
doi = {10.2147/ccid.s647223}
}
EUVIMED